NCT00840957View on ClinicalTrials.gov

Pharmaco Kinetic Variability of Infliximab in Rheumatoid Arthritis

CompletedOBSERVATIONAL
Enrollment

84

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions
Rheumatoid Arthritis
Interventions
BIOLOGICAL

infliximab

chimeric monoclonal antibody to Tumor Necrosis Factor-alpha

Trial Locations (6)

Unknown

CHRU de Brest, Brest

CHRU de Nantes, Nantes

CHR d'Orléans, Orléans

CHRU de Poitiers, Poitiers

CHRU de Rennes, Rennes

CHRU de Tours, Tours

All Listed Sponsors
lead

University Hospital, Tours

OTHER

NCT00840957 - Pharmaco Kinetic Variability of Infliximab in Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter